| Literature DB >> 22558437 |
Yi-Chun Chen1, Yu-Chieh Su, Ching-Chih Lee, Yung-Sung Huang, Shang-Jyh Hwang.
Abstract
BACKGROUND: Cardiovascular disease (CVD) is a leading cause of mortality and morbidity in patients with chronic kidney disease (CKD). In Taiwan, CVD is dominated by strokes but there is no robust evidence for a causal relationship between CKD and stroke. This study aimed to explore such causal association.Entities:
Mesh:
Year: 2012 PMID: 22558437 PMCID: PMC3340358 DOI: 10.1371/journal.pone.0036332
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic characteristics and comorbidities of the primary chronic kidney disease (CKD) and control groups in Taiwan, 2004–2007 (n = 2786).
| Variables | Primary CKD group (n = 1393) n (%) | Control group (n = 1393) n (%) |
|
|
| 0.003 | ||
| Male | 657 (47.2) | 735 (52.8) | |
| Female | 736 (52.8) | 658 (47.2) | |
|
| NA | ||
| 25–44 | 177 (12.7) | 177 (12.7) | |
| 45–54 | 196 (14.1) | 196 (14.1) | |
| 55–64 | 175 (12.6) | 175 (12.6) | |
| 65–74 | 338 (24.3) | 338 (24.3) | |
| >75 | 507 (36.4) | 507 (36.4) | |
|
| <0.001 | ||
| Yes | 0 (0.0) | 118 (8.5) | |
| No | 1393 (100) | 1275 (91.5) | |
|
| <0.001 | ||
| Yes | 0 (0.0) | 179 (12.8) | |
| No | 1393 (100) | 1214 (87.2) | |
|
| <0.001 | ||
| Yes | 0 (0.0) | 88 (6.3) | |
| No | 1393 (100) | 1305 (93.7) | |
|
| 0.157 | ||
| Yes | 0 (0.0) | 2 (0.1) | |
| No | 1393 (100) | 1391 (99.9) | |
|
| 0.175 | ||
| Northern | 683 (49.0) | 722 (51.8) | |
| Central | 287 (20.6) | 242 (17.4) | |
| Southern | 386 (27.7) | 391 (28.1) | |
| Eastern | 37 (2.7) | 38 (2.7) | |
|
| 0.024 | ||
| Urban | 322 (23.1) | 384 (27.6) | |
| Suburban | 587 (42.1) | 544 (39.1) | |
| Rural | 484 (34.7) | 465 (33.4) | |
|
| 0.001 | ||
| 1–2 | 359 (25.8) | 449 (32.2) | |
| 3 | 678 (48.7) | 609 (43.7) | |
| 4 | 356 (25.6) | 335 (24.0) |
Values are given as number (percentage).
Crude and adjusted hazard ratios for stroke among the primary chronic kidney disease (CKD) and control groups during the three-year follow-up period (n = 2786).
| Development of Stroke | Control group (n = 1393) n (%) | Primary CKD group (n = 1393) n (%) |
|
|
| <0.001 | ||
| Yes | 100 (7.2) | 156 (11.2) | |
| No | 1293 (92.8) | 1237 (88.8) | |
|
| 1 | 1.57 (1.22–2.02) | <0.001 |
|
| 1 | 1.94 (1.45–2.60) | <0.001 |
Abbreviations: 95% CI = 95% confidence interval; HR = hazard ratio.
Adjustments are made for patient's age, gender, diabetes, hypertension, coronary heart disease, hyperlipidemia, geographic region, urbanization level, and enrollee category.
Figure 1Cumulative risk of stroke for the primary chronic kidney disease and appendectomy (control) groups in the 3-year follow-up.
Three-year cumulative risk of stroke among the control and primary chronic kidney disease (CKD) groups (n = 2786)a.
| Control group (n = 1393) | Primary CKD group (n = 1393) | ||||||
| Propensity score stratum | No. | % of stratum | Cumulative risk (%) | No. | % of stratum | Cumulative risk (%) |
|
| 1 | 458 | 82 | 10.5 | 99 | 18 | 4 | 0.048 |
| 2 | 276 | 50 | 1.8 | 281 | 50 | 7.2 | 0.002 |
| 3 | 242 | 43 | 7.6 | 316 | 57 | 10.5 | 0.215 |
| 4 | 221 | 40 | 6.4 | 336 | 60 | 12.5 | 0.019 |
| 5 | 196 | 35 | 8.2 | 361 | 65 | 17.3 | 0.003 |
| Total | 1393 | 6.9 | 1393 | 10.3 | <0.001 | ||
| 0.001 | |||||||
Stratum 1 had the strongest propensity for control; stratum 5, for primary chronic kidney disease.
Conchran-Mantel-Haenszel statistics; adjusted odds ratio = 1.68, 95% confidence interval = 1.25–2.25.
Crude and adjusted hazard ratios for stroke among the primary chronic kidney disease (CKD) and control groups younger than 75 years old and without comorbidities during the three-year follow-up period (n = 1617).
| Development of Stroke | Control group (n = 731) n (%) | Primary CKD group (n = 886) n (%) |
|
|
| <0.001 | ||
| Yes | 16 (2.2) | 72 (8.1) | |
| No | 715 (97.8) | 814 (91.9) | |
|
| 1 | 3.54 (2.06–6.10) | <0.001 |
|
| 1 | 3.56 (2.06–6.13) | <0.001 |
Abbreviations: 95% CI = 95% confidence interval; HR = hazard ratio.
Adjustments are made for patient's age, gender, diabetes, hypertension, coronary heart disease, hyperlipidemia, geographic region, urbanization level, and enrollee category.